Algen Biotechnologies partners with AstraZeneca in $555m deal to advance AI-driven drug discovery in immunology
Algen Biotechnologies has entered a multi-target partnership with AstraZeneca to leverage its AI-powered AlgenBrain platform for identifying novel therapeutic targets in immunology, with the collaboration aimed at accelerating next-generation treatment discovery